bio2018-mybio-sessionicon-companypres

Landos Biopharma

4:15 PM–4:30 PM Jun 5, 2018 (US - Eastern)

Theater 2, Level 0

Description

Provide an update on the progress that Landos is making to advance BT-11, its lead asset for IBD, to

Session ID: 22022

Tags